Drugs / CBD
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05052541 | Jan 2026 → Jun 2027 expected | spondylosis, cervical | University of Colorado, Denver | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05052541 ↗ |
| Route | Oral | “Oral solution containing 5mg THC and 50 mg CBD per 1 ml” NCT05052541 ↗ |